PEDIATRICS Vol. 28 No. 6 December 1961, pp. 962-970
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pearson, C. M.
Right arrow Articles by Griffith, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pearson, C. M.
Right arrow Articles by Griffith, W. H.

STUDIES OF ENZYMES IN SERUM IN MUSCULAR DYSTROPHY

II. Diagnostic and Prognostic Significance in Relatives of Dystrophic Persons

Carl M. Pearson M.D.1, Sudhir R. Chowdhury Ph.D.1, William M. Fowler Jr. M.D.1, Margaret H. Jones M.D.1, and Wendell H. Griffith Ph.D.1

1 Departments of Medicine, Physiological Chemistry and Pediatrics, and the Division of Neurology, School of Medicine, University of California, Los Angeles, and the Wadsworth Hospital, Veterans Administration Center, Los Angeles

Progressive muscular dystrophy is one of the relatively few chronic diseases in which an increase of various enzymes in serum is of diagnostic value. In the presence of muscular weakness high levels indicate a primary myopathic process. It has previously been shown that elevated values for enzymes in serum are most pronounced in childhood dystrophy, are highest early in the disease, and taper toward normal several years later.

This study involves a clinical and biochemical analysis of several families in which dystrophy is known to exist. An elevation of the enzymes studied (two transaminases, aldolase, two dehydrogenases) was found in several young boys who were at the time clinically asymptomatic. In one family the youngest of these children was 4frac12 months of age. Three of his brothers developed clinical dystrophy at about 3 years of age. In another family clinical follow-up for 3 years after the finding of elevated levels of enzymes in serum has shown the development of early muscular weakness in two male cousins of a known dystrophic person. Muscle biopsy in the preclinical stage has shown dystrophic changes in each of five cases.

The diagnostic and prognostic significance of enzyme levels in serum in families of dystrophic persons is impressive. It appears that in some forms of dystrophy the time of onset of the disease is very early in life, or even in the prenatal period. The enzyme studies have provided the first objective evidence that this may be the case.